LobbyingAstria Therapeutics lobbying by quarter
Astria Therapeutics's latest lobbying report covers Q4 2025, at $40K. The four quarters Q4 2025–Q3 2026 total $40K. Its first report covers Q3 2023; the issues it reports most are Pharmacy.
Astria Therapeutics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $40K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q3 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2023 | $0 | 1 |
| Q4 2023 | $40K | 1 |
| Q1 2024 | $40K | 1 |
| Q2 2024 | $40K | 1 |
| Q3 2024 | $40K | 1 |
| Q4 2024 | $40K | 1 |
| Q1 2025 | $40K | 1 |
| Q2 2025 | $40K | 1 |
| Q3 2025 | $40K | 1 |
| Q4 2025 | $40K | 1 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Pharmacy$280K · 7 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES7 reports
- SENATE6 reports
Firms it paid
| Firm | ||
|---|---|---|
| The KPM Group DC | $360K | 10 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 01/20for Q4 2025 | The KPM Group DC | $40K |
| 25/10/17for Q3 2025 | The KPM Group DC | $40K |
| 25/07/17for Q2 2025 | The KPM Group DC | $40K |
| 25/04/21for Q1 2025 | The KPM Group DC | $40K |
| 25/01/21for Q4 2024 | The KPM Group DC | $40K |
| 24/10/21for Q3 2024 | The KPM Group DC | $40K |
| 24/07/19for Q2 2024 | The KPM Group DC | $40K |
| 24/04/19for Q1 2024 | The KPM Group DC | $40K |
| 24/01/22for Q4 2023 | The KPM Group DC | $40K |
| 23/10/20for Q3 2023 | The KPM Group DC | Under $5,000 |
| 23/09/27for Q3 2023 | The KPM Group DC | Under $5,000 |